Program | Speaker |
|---|---|
Welcome and Introduction | Chair: Nicole Lamanna (New York City, USA) |
Management of CLL and Associated Infection Risk | Livio Trentin (Padua, Italy) |
Treatment Approaches in CLL and Infection Prevention Strategies | Nicole Lamanna (New York City, USA) |
Who May Benefit Most from Immunoglobulin Replacement Therapy? | Antoine Azar (Baltimore, USA) |
Panel Discussion | All Faculty |
Q&A | All Faculty |
Closing Remarks | Chair: Nicole Lamanna (New York City, USA) |
Sweden12/06/2026
Infection Prevention and Immune Support in CLL
Octapharma Update-in-Hematology at EHA 2026
)
Strengthening Care in Chronic Lymphocytic Leukemia (CLL):
Strategies for Infection Prevention and Immune Support
Friday, June 12, 2026 | 10:00 - 11:30
Stockholmsmässan Convention Center, Stockholm, Sweden
Summary of the session
Patients with chronic lymphocytic leukemia (CLL) face a substantial risk of infections driven both by disease-related immune dysfunction and by immuno-suppressive therapies. As treatment strategies evolve, balancing disease control with infection prevention is becoming a critical component of comprehensive CLL care.
This session aims to deepen understanding of infection risk in CLL, with a focus on how disease-related immune dysfunction and immunosuppressive therapies contribute to SID. Participants will explore practical strategies for infection prevention, in particular immunoglobulin replacement therapy, supported by current clinical evidence and expert recommendations.
Programme
Chair: Nicole Lamanna
This scientific information may include data/information on investigational uses of compounds/drugs that have not yet been approved by regulatory authorities. This program was developed for use outside the U.S., is intended for non-U.S. HCPs, and is to be used in accordance with local laws and regulations.
Meet the speakers
Nicole Lamanna
Columbia University Medical Center, New York City, USA
Livio Trentin
University of Padua, Padua, Italy
Antoine Azar
Johns Hopkins University School of Medicine, Baltimore, USA
To attend this Update-in-Hematology, register to the EHA 2026 Congress.